Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of High Risk Adult Acute Lymphoblastic Leukemia
NCT00853008Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jan 2003
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 4 trial of vincristine sulfate liposome injection, daunorubicin, prednisone, mitoxantrone hydrochloride liposome injection + fludarabine + CD19 CAR-T cells, cytarabine in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Started Jan 2003; status: completed.
02
Drugs
vincristine sulfate liposome injectiondaunorubicinprednisonemitoxantrone hydrochloride liposome injection + fludarabine + CD19 CAR-T cellscytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00853008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853008.